Search

everythinglearnresearchcommunity

for

Search:↓

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Minoxidil helps hair regrowth, especially with more indeterminate hairs.

More vellus hairs in frontal scalp indicate early female pattern hair loss.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

A woman experienced temporary hair loss after taking albendazole, which resolved on its own within 3 months.

Accidental findings have led to new hair treatment discoveries, like using blood pressure and diabetes medications for hair loss and unwanted hair.

A 35-year-old man had patchy hair loss that was actually due to syphilis, not alopecia areata.

A woman with discoid lupus improved with treatment after being misdiagnosed with a different hair loss condition.

A positive anagen pull test can help detect active Lichen Planopilaris.

Many treatments for alopecia areata have inconsistent results; for under 10s, use minoxidil with a corticosteroid, and for over 10s, add ILC and consider diphenylcyclopropenone for widespread cases.

Title change to "Central Centrifugal Cicatricial Alopecia (CCCA)"; common in African American women; hair-grooming methods may contribute; no effective therapy found; trials needed.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

The study found that Frontal Fibrosing Alopecia affects a broader age range of women and early treatment can help stop hair loss.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

The review emphasizes the need to recognize skin conditions that affect hair follicles and sweat glands to avoid misdiagnosis.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Demodex mites rarely cause scalp infections leading to hair loss, but when they do, treatment is effective.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

A rare case of a woman having both lichen planus pigmentosus and classic lichen planopilaris at the same time.